Risk Factors of Peritoneal Recurrence and Outcome of Resected Peritoneal Recurrence After Liver Resection in Hepatocellular Carcinoma: Review of 1222 Cases of Hepatectomy in a Tertiary Institution

Overview

Journal Ann Surg Oncol

Publisher Springer

Specialty Oncology

Date 2012 Mar 10

PMID 22402812

Citations 23

Authors

Alfred Wei Chieh Kow

Choon Hyuck David Kwon

Sanghyun Song

Milljae Shin

Jong Man Kim

Jae-Won Joh

Affiliations

Soon will be listed here.

Abstract

Background: Reports on the risk factors of peritoneal recurrence (PR) after liver resection for hepatocellular carcinoma are lacking. We examined the risk factors of PR after hepatectomy and the outcome of resected PR at our institution.

Methods: We retrospectively reviewed the data from 1,222 patients who underwent hepatectomies for hepatocellular carcinoma in Samsung Medical Center from January 2006 to August 2010. We identified patients with PR and studied the risk factors and outcomes of resected PR.

Results: The rate of PR was 3.0% (n=36). The mean±SD age of patients was 54.0±10.2 years. Among those with PR, 23 patients (63.9%) had unresectable disease and 13 patients (36.1%) had resectable disease. Multivariate analysis found that tumor size>50 mm, presence of microvascular invasion, bile duct invasion, and positive margins were significant risk factors of PR after liver resection. The median overall survival (OS) for resectable PR was 33.0 (28.0-61.6) months compared to 14.0 (6.8-21.2) months for unresectable PR (P=0.009). Cox regression analysis demonstrated that resected PR [hazard ratio (HR) 0.042, P = 0.001] and interval between hepatectomy and PR (>6 months) (HR 0.195, P=0.016) were positive prognostic factors for OS, while alfa-fetoprotein>200 ng/dl at detection of PR (HR 11.321, P=0.015) and serosal involvement of primary hepatocellular carcinoma (HR 25.616, P=0.007) were negative prognostic factors for OS.

Conclusions: We found that tumor size>50 mm, presence of microvascular invasion, bile duct invasion, and positive resection margins were significant risk factors of PR after liver resection. Selected patients with resected PR had significantly better OS.

Citing Articles

Long-term survival outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastasis of hepatocellular carcinoma patients.

Yan G, Zhang K, Yan L, Zhang Y World J Surg Oncol. 2024; 22(1):144.

PMID: 38822337 PMC: 11140955. DOI: 10.1186/s12957-024-03426-1.

Prevalence, patterns, risk factors and outcomes of peritoneal metastases after laparoscopic hepatectomy for hepatocellular carcinoma: a multicenter study from China.

Lu Y, Zhao J, Yuan G, Hu M, Sun C, Chen K Hepatobiliary Surg Nutr. 2024; 13(1):3-15.

PMID: 38322199 PMC: 10839707. DOI: 10.21037/hbsn-22-506.

Surgical Treatment of Postoperative Abdominal Metastases of Hepatocellular Carcinoma: 10-Year Experience in a Single Center.

Fang J, Yang Y, Zhu H, Sun J, Mi H, Lu C Cancer Manag Res. 2021; 13:8673-8683.

PMID: 34849024 PMC: 8612661. DOI: 10.2147/CMAR.S328250.

Development of a novel prognostic nomogram for the early recurrence of liver cancer after curative hepatectomy.

Xia W, Peng T, Guan R, Zhou Y, Zeng C, Lin Y Ann Transl Med. 2021; 9(20):1541.

PMID: 34790747 PMC: 8576734. DOI: 10.21037/atm-21-4837.

Usefulness and limitation of indocyanine green fluorescence for detection of peritoneal recurrence after hepatectomy for hepatocellular carcinoma: a case report.

Hayashi H, Shimizu A, Motoyama H, Kubota K, Notake T, Sugenoya S BMC Surg. 2021; 21(1):107.

PMID: 33653302 PMC: 7923305. DOI: 10.1186/s12893-021-01111-8.

References

Llovet J, Fuster J, Bruix J . Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999; 30(6):1434-40. DOI: 10.1002/hep.510300629. View

Yoshida H, Onda M, Tajiri T, Akimaru K, Takasaki H, Mamada Y . Successful surgical treatment of peritoneal dissemination of hepatocellular carcinoma. Hepatogastroenterology. 2002; 49(48):1663-5. View

Ryu J, Lee S, Kim K, Yoh K . Surgical treatment in a patient with multiple implanted intraperitoneal metastases after resection of ruptured large hepatocellular carcinoma. Hepatogastroenterology. 2004; 51(55):239-42. View

Poon R, Fan S, Lo C, Liu C, Wong J . Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg. 1999; 229(2):216-22. PMC: 1191634. DOI: 10.1097/00000658-199902000-00009. View

McGlynn K, Tsao L, Hsing A, Devesa S, Fraumeni Jr J . International trends and patterns of primary liver cancer. Int J Cancer. 2001; 94(2):290-6. DOI: 10.1002/ijc.1456. View

Eriguchi N, Aoyagi S, Okuda K, Tamae T, Fukuda S, Kanazawa N . Successful surgical treatment for implanted intraperitoneal metastases of hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2001; 7(5):520-3. DOI: 10.1007/s005340070025. View

Fong Y, Sun R, Jarnagin W, Blumgart L . An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg. 1999; 229(6):790-9; discussion 799-800. PMC: 1420825. DOI: 10.1097/00000658-199906000-00005. View

Lin C, Liang H, Lee H, Huang G, Yang P, Ho M . Clinical manifestations and survival of hepatocellular carcinoma patients with peritoneal metastasis. J Gastroenterol Hepatol. 2009; 24(5):815-20. DOI: 10.1111/j.1440-1746.2009.05848.x. View

Lee Y, Geer D . Primary liver cancer: pattern of metastasis. J Surg Oncol. 1987; 36(1):26-31. DOI: 10.1002/jso.2930360107. View

10.

Jung K, Won Y, Park S, Kong H, Sung J, Shin H . Cancer statistics in Korea: incidence, mortality and survival in 2005. J Korean Med Sci. 2009; 24(6):995-1003. PMC: 2775885. DOI: 10.3346/jkms.2009.24.6.995. View

11.

Hung M, Wu H, Lee Y, Hsu C, Chou D, Huang M . Intraperitoneal metastasis of hepatocellular carcinoma after spontaneous rupture: a case report. World J Gastroenterol. 2008; 14(24):3927-31. PMC: 2721456. DOI: 10.3748/wjg.14.3927. View

12.

Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Yamamoto J, Shimada K . Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology. 1998; 28(5):1241-6. DOI: 10.1002/hep.510280511. View

13.

Kosaka A, Hayakawa H, Kusagawa M, Takahashi H, Okamura K, Mizumoto R . Successful surgical treatment for implanted intraperitoneal metastases of ruptured small hepatocellular carcinoma: report of a case. Surg Today. 1999; 29(5):453-7. DOI: 10.1007/BF02483040. View

14.

Nakayama H, Takayama T, Makuuchi M, Yamasaki S, Kosuge T, Shimada K . Resection of peritoneal metastases from hepatocellular carcinoma. Hepatogastroenterology. 1999; 46(26):1049-52. View

15.

Cha C, Fong Y, Jarnagin W, Blumgart L, DeMatteo R . Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg. 2003; 197(5):753-8. DOI: 10.1016/j.jamcollsurg.2003.07.003. View

16.

Song I, Kim K . Current status of liver diseases in Korea: hepatocellular carcinoma. Korean J Hepatol. 2009; 15 Suppl 6:S50-9. DOI: 10.3350/kjhep.2009.15.S6.S50. View

17.

Dixon J, Nirmul D, Eremin O . Haemoperitoneum due to traumatic rupture of a hepatoma in a patient with haemochromatosis. J R Coll Surg Edinb. 1982; 27(6):362-3. View

18.

Adachi E, Maeda T, Matsumata T, Shirabe K, Kinukawa N, Sugimachi K . Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology. 1995; 108(3):768-75. DOI: 10.1016/0016-5085(95)90450-6. View

19.

. Primary liver cancer in Japan. Sixth report. The Liver Cancer Study Group of Japan. Cancer. 1987; 60(6):1400-11. DOI: 10.1002/1097-0142(19870915)60:6<1400::aid-cncr2820600639>3.0.co;2-w. View

20.

Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M . Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology. 2000; 32(6):1224-9. DOI: 10.1053/jhep.2000.20456. View